MDMA-Assisted Therapy for PTSD Awaits FDA Decision
December 21, 2023
Jennifer Mitchell, PhD, discusses MAPS Public Benefit Corporations’ recent New Drug Application submission for MDMA-Assisted Therapy for PTSD and what the treatment’s potential approval could mean for people with PTSD.